Assessment of TROP2, CEACAM5 and DLL3 in metastatic prostate cancer: Expression landscape and molecular correlates

Azra Ajkunic(Emory University), Michael C. Haffner(Memorial Sloan Kettering Cancer Center)
npj Precision Oncology
May 17, 2024
Cited by 29


Related Papers